JMP Securities Reiterates Market Perform on Apyx Medical
Portfolio Pulse from Benzinga Newsdesk
JMP Securities analyst David Turkaly has reiterated a Market Perform rating on Apyx Medical (NASDAQ:APYX).

September 16, 2024 | 1:53 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
JMP Securities has reiterated a Market Perform rating for Apyx Medical, indicating a neutral stance on the stock's performance.
The reiteration of a Market Perform rating suggests that the analyst sees no significant changes in the company's outlook. This neutral rating implies that the stock is expected to perform in line with the market, which may not lead to immediate price changes.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100